Share on

Europe In-Vitro Fertilization Market Research Report – Segmented By Reagents & Media, Instruments, Technology, End Users & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) – Size, Share, Trends and Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 260
Pages: 145
Formats: report pdf report excel report power bi report ppt

Europe In-vitro Fertilization Market Size (2022 to 2027)

The size of the In-Vitro fertilization (IVF) market in Europe is expected to reach USD 2.01 billion by 2027 from USD 0.98 billion in 2022, growing at a CAGR of 15.4% during the forecast period.

The in vitro fertilization market in Europe is expected to experience steady and continuous growth, mainly in France, Germany, and the United Kingdom. This is due to supporting regulations such as the UK Human Fertilization and Embryo Authority (HFEA), which tightly regulates the operation of in vitro fertilization treatments and research in the UK. The subsidy of IVF treatments in Germany due to the falling birth rate of around 2.21 children/women is an essential factor in the growth of this market. Besides, the National Health Plan (PSN) covers approximately 50% of the total cost of treatment. It supports three cycles of in vitro fertilization, which is expected to boost the in vitro fertilization market, especially in Germany.

The main factors limiting this market growth are costs incurred and strict government regulations. A patient may need to have multiple pregnancy cycles due to the lower success rate of IVF procedures, which increases the total cost. The average cost of this procedure is approximately $ 15,125 to $ 25,300, which is often a significant barrier to adopting the technique. Besides, ethical considerations and lack of reimbursement are other challenges that are hampering the growth of the market.

This research report on the Europe In-vitro Fertilization Market has been segmented and sub-segmented into the following categories:

  • By Reagents and Media: Embryo Culture Media, Cryopreservation Media, Sperm Processing Media, Ovum Processing Media
  • By Instruments: Imaging Systems, Sperm Separation Systems, Ovum Aspiration Pumps, Incubators, Micromanipulator Systems, Cryosystems and Other Instruments (Gas Analyzers, Laser Systems, Accessories)
  • By Technology: Intra-Cytoplasmic Sperm Injection (ICSI), Pre-Implantation Genetic Diagnosis (PGD), Frozen Embryo Transfer/Replacement (FET/FER), and Other Technologies                             
  • By End Users: Fertility and Surgical Centers, Hospitals and Research Laboratories, Cryobanks
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic, and Rest of Europe

Regional Analysis:

The European region enjoys an excellent reputation in the global IVF market, as it was the first region to introduce the IVF procedure. Besides, Europe has been one of the champions of the legalization of trip rental in vitro fertilization or the mitochondrial transfer technique. The Spanish market is expected to accelerate with the highest CAGR by the end of 2025.

However, in terms of revenue, the UK IVF market is expected to dominate this region. The in vitro fertilization market in Europe is expected to experience steady and continuous growth, mainly in France, Germany, and the United Kingdom. This is due to supporting regulations such as the UK Human Fertilization and Embryo Authority (HFEA), which tightly regulates the operation of in vitro fertilization treatments and research in the UK. France accounted for the highest number of IVF cycles per year in 2020, while the UK is expected to grow at the highest CAGR in terms of volume and value. Spain is expected to be the main contributor to the region's overall revenues, with a CAGR of 7.2.1%, due to the increase in fertility tourism and the high success rates of the treatments provided. The UK is expected to have the highest growth rate of the European IVF market, with a CAGR of 8.1%, in terms of revenue. In 2020, the EU5 (Germany, France, United Kingdom, Spain, and Italy) collectively accounted for around three-fifths of the market volume.

Companies playing a dominant role in the European in-Vitro fertilization Market profiled in this report are Cooper Surgical, Inc. (U.S.), Vitrolife AB (Sweden), Cook Medical, Inc. (U.S.), Irvine Scientific (U.S.), Thermo Fisher Scientific, Inc. (U.S.), EMD Serono, Inc. (U.S.), Genea Limited (Australia), ESCO Micro Pte. Limited (Singapore), IVFtech ApS (Denmark), and The Baker Company, Inc. (U.S.).

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample